SKL-SZP

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSKL-SZP
Drug Alias NamemGluR5 PAMs (SK Pharmaceuticals)SKL-SZP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 modulators
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSK Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSK Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A